Abstract

It is now recognized that there is considerable variation in the clinical manifestations,<sup>1,2</sup>the origin, and character of metastatic carcinoid tumors. A malabsorption syndrome<sup>3</sup>and scleroderma<sup>4</sup>may accompany the carcinoid syndrome. This syndrome may be produced by bronchial carcinoids with metastases,<sup>5-8</sup>oat-cell carcinoma,<sup>9</sup>argentaffinoma of the lung without hepatic metastases,<sup>10</sup>and pancreatic carcinoma with demonstrated 5-hydroxytryptophan decarboxylase activity.<sup>11</sup>The syndrome is apparent in only 20% of patients with carcinoid tumors and hepatic metastases<sup>12</sup>and may rarely be associated with normal levels of 5-hydroxyindoleacetic acid (5-HIAA) excretion in the urine.<sup>13,14</sup> The possible association of carcinoid syndrome and Cushing's syndrome has been suggested by the report of Harrison<sup>15</sup>of a patient with bronchial carcinoma and clinical features of adrenal hyperplasia. In their patient 17-ketosteroid excretion was normal and 5-HIAA excretion in the urine was moderately increased as shown by paper chromatography.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call